期刊文献+

AS_2O_3对CD34^+白血病细胞NKG2D配体表达及NK杀伤活性的影响 被引量:8

The effects of arsenic trioxide on the expression of NKG2D ligands in CD34^+ AML KG1a cells and its impact on NK cytotoxicity
在线阅读 下载PDF
导出
摘要 目的:观察AS2O3对CD34+早期急性髓系白血病细胞NKG2D配体表达及NK细胞杀伤活性的影响。方法:流式细胞仪检测KG1a细胞表面CD34抗原表达率,MTT法确定AS2O3的基本工作浓度,以不同浓度的AS2O3处理KG1a细胞,流式细胞仪测定处理前后KG1a细胞NKG2D配体的表达情况;MACS法分离5例健康个体的NK细胞,LDH释放法检测NK细胞对AS2O3处理前后KG1a细胞的杀伤活性。结果:10nmol/ml的AS2O3作用KG1a细胞后,能使KG1a细胞表面ULBP1的表达水平显著上调(P<0.05),同时也激发了NK细胞对KG1a细胞的杀伤活性(P<0.05)。结论:AS2O3能上调CD34+白血病细胞表面NKG2D配体的表达水平,诱导NK细胞对其的杀伤活性,启示AS2O3可与NK细胞组成过继性免疫化疗方案,提高急性白血病的疗效。 Objective: To explore the effects of arsenic trioxide (As2O3) on expression of NKG2D ligands on the surface of CD34^+ AML cells and its impact on normal NK cytotoxicity. Methods: Expression of CD34 antigen on KGla cells, a cell line of acute myelogenous leukemia (AML) ,was detected by FACS. KGla cells were treated by AS2O3 in different concentrations, then expression of NKG2D ligands on the cells was observed with FACS. NK cells were isolated from 5 healthy persons with MACS and their cytotoxicity was detected by LDH releasing assay. Results:Expression of ULBP1 on KGla cells was increased when incubated with 10 nmol/ml of AS2O3( P 〈 0.05). Cytotoxicity of NK cells from normal individuals against the AS2O3-treated KGla cells was enhanced significantly( P 〈 0.05). Conclusion: AS2O3 increases the expression of NKG2D ligands on CD34 ^+ leukemia cells, which induces enhanced NK cytotoxicity.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第6期509-511,517,共4页 Chinese Journal of Immunology
基金 国家自然科学基金资助项目(30471636)
关键词 急性髓系白血病 NK细胞 NKG2D配体 AS2O3 细胞毒性实验 Acute myeloid leukemia(AML) NK cell NKG2D ligand AS2O3 Cytotoxicity experiment
  • 相关文献

参考文献13

  • 1Ranlet D H. Roles of the NKG2D immunoreceptor and its ligands[J]. Nat Rev Immunol, 2003 ; 3 : 781-790.
  • 2Trinchieri G. The choices of a natural killer[ J]. Nat Immunol, 2003;4: 509-510.
  • 3Cosman D, Mullberg J, Sutherland C Let all. ULBPs, novel MHC class Ⅰ - related molecules,bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor[ J]. Immunity, 2001 ; 14 : 123-133.
  • 4Hasenkamp J, Borgerding A, Wulf G et al. Resistance against natural killer cell cytotoxicity: analysis of mechanisms [ J ]. Immunol, 2006; 64: 444-449.
  • 5Nowbakht P, Ionescu M C, Rohner A et al. Ligands for natural killer cell- activating receptors are expressed upon the maturation of normal myelomonecytic cells but at low levels in acute myeloid leukemias[J].Blood,2005;105:3615-3622.
  • 6Wang Z Y. Arsenic compounds as anticancer agents[J]. Cancer Chemother Pharmacol, 2001 ; 48 (Suppl 1 ) : S72-S76.
  • 7Bumett A K. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation-an adult treater's view[ J ]. Br J Hematol, 2002; 118: 357-364.
  • 8Ruggeri L, Mancusi A, Capanni M et al. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer[ J ]. Curt Opin Immunol, 2005 ; 17: 211-217.
  • 9梅家转,牛新清,郭坤元,周健,魏红梅.K562和K562/AO2细胞HLA I类分子与MICA/B的表达及其对NK细胞杀伤活性的影响[J].中国实验血液学杂志,2007,15(2):288-291. 被引量:10
  • 10梅家转,郭坤元,魏红梅,宋朝阳.NKG2D配体在耐药鼻咽癌细胞的表达及其对NK细胞杀伤活性的影响[J].南方医科大学学报,2007,27(6):887-889. 被引量:4

二级参考文献27

  • 1栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 2邹萍,向建平,陈智超,李崇渔.急性髓系白血病细胞CD_(34)抗原表达的研究Ⅰ表达特点和临床意义[J].中华血液学杂志,1994,15(7):339-341. 被引量:28
  • 3操州虹,刘秀芳,王辨明.不同病期慢性粒细胞白血病CD_(34)阳性细胞的临床意义[J].中华血液学杂志,1996,17(1):10-12. 被引量:3
  • 4Osawa M,Hanada K, Hamada H, et al. Long-term lymphohematopoietic reconstitution by a single CD34 - low/negative hematopietic stem cell [J]. Science, 1996,273 (5272): 242 - 245.
  • 5Huss R. CD34 - stem cells as the earliest precursors of hempatopoietic progeny[J]. Exp Hematol,1998,26(11) :1022 - 1023.
  • 6Halens S, Kohn DB. Gene therapy using hematopoietic stem cells:sisyphus approaches the cerst[J]. Human Gene Therapy,2000,11(9) :1259 - 1267.
  • 7Cornelissen JJ, Vander Hdt B, Petersen EJ, et al. A randomized multicenter comparison of CD34 +-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies [J]. Exp Hematol,2003,31 (10) :855 -864.
  • 8Vogle W, Behringer D, Scheding S, et al. Ex vivo expansion of CD34 + peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells[J]. Blood,1996,88(7) :2707 -2713.
  • 9Brugger W, Heimfeld S, Berenson RJ, et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo[J]. N Eng J Med, 1995,333 (5) :283 -287.
  • 10Harraz M, Jiao C, Hanlon HD, et al. CD34- blood-derived human endothelial cell progenitors[J]. Stem Gells,2001,19(4) :304-312.

共引文献62

同被引文献44

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部